1. Home
  2. Live Updates
  3. Generic

Live Breaking News & Updates on Generic

Stay informed with the latest breaking news from Generic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Generic and stay connected to the pulse of your community

Talking Point 2023/2024 - We test how effective are cheaper & generic medicines from Malaysia

Do you stock up on generic drugs when you travel to Malaysia? Or buy medication from online retailers that deliver to Singapore? In this #TalkingPoint experiment, we test the potency of such medicines to see if they are really effective.

Singapore , Malaysia , Medicines , Generic , Drugs ,

Sandoz to Pay $265 Mln in U.S. to Solve Generic Drug Antitrust Litigation

By Mauro Orru Sandoz Group said its U.S. subsidiaries would pay $265 million to settle a generic pharmaceuticals pricing antitrust litigation. The maker of...

Pennsylvania , United-states , Mauro-orru , Us-district-court , Sandoz-group , Eastern-district , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Anti-competition-issues , Corporate-industrial-news

David Einhorn's Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy

Greenlight Capital picks up a new stake in Kenvue Inc, formerly the consumer healthcare division of Johnson & Johnson.

Israel , Israeli , David-einhorn , Kenvue-inc , Teva-pharmaceutical-industries-ltd , Exchange-commission , Greenlight-capital , Teva-pharmaceutical-industries , Article-normal , Hedgefund , Energy , Oil-and-gas-upstream-operations

1 in 5 Most Costly Generics Not Available Through National Direct-to-Consumer Pharmacies

Amazon and Health Warehouse’s direct-to-consumer pharmacies had the most expensive and commonly used generic drugs available in 2020, whereas Walmart only had a small fraction.

Cuba , Cuban , Mark-cuban-cost-plus-drug-company , Walmart , Costco , Mark-cuban-cost-plus-drugs-company , Health-warehouse , Mark-cuban-cost-plus-drugs , General-internal-medicine , Mark-cuban-cost-plus-drug , Medicare

Teva Plans to Divest API Business as Part of Strategic Pivot

By Adriano Marchese Teva Pharmaceutical Industries plans to divest its active-pharmaceutical ingredient business as it looks to pursue new growth...

Tel-aviv , Israel , Richard-francis , Adriano-marchese , Teva-pharmaceutical-industries , Pharmaceutical-industries , Chief-executive-richard , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Corporate-strategy-planning

Teva Pharmaceutical 4Q Adj Profit, Revenue Beat Expectations

By Adriano Marchese Teva Pharmaceutical Industries on Wednesday reported a swing-to-a-profit in the fourth quarter, with revenue beating expectations, and...

Adriano-marchese , Teva-pharmaceutical-industries-on , Pharmaceutical-industries , Tel-aviv-based , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Financial-performance , Earnings , Corporate-industrial-news , Content-types

Teva Pharmaceutical 2022 Loss Wider After Discovering Accounting Errors

By Adriano Marchese Teva Pharmaceutical Industries said Wednesday its loss in 2022 was deeper after discovering errors related to estimated future royalty...

Tel-aviv , Israel , Adriano-marchese , Teva-pharmaceutical-industries , Pharmaceutical-industries , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Corporate-industrial-news , Synd , Teva-tv

Teva Pharmaceutical Shares Hit 52-Week High After 4Q Earnings Beats Estimates

By Adriano Marchese Shares of Teva Pharmaceutical Industries were trading higher on Wednesday after the company reported better-than-expected revenue and...

Tel-aviv , Israel , Adriano-marchese , Teva-pharmaceutical-industries , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Financial-performance , Earnings , Earnings-surprises , Share-price-movement-disruptions

Teva Stock Gains. The Company Will Divest Drug Ingredients Business.

Teva has struggled for years with enormous debts and litigation over its role in the opioid crisis.

Israel , France , French , Josh-nathan-kazis , David-williams-bloomberg , Richard-francis , Teva-adrs , Teva-pharmaceutical-industries , Allergan , Wall-street , Article-normal , Pharmaceuticals

Viatris, Cooper Consumer Health Sign Transaction Deal

By Sabela Ojea Viatris has signed a transaction agreement with Cooper Consumer Health, according to a Securities and Exchange Commission filing on Tuesday....

France , Sabela-ojea , Exchange-commission , Cooper-consumer-health , Article-normal , Pharmaceuticals , Healthcare-life-sciences , Generic-biosimilar-drugs , Corporate-industrial-news , Synd , Viatris , Vtrs